Evidence map›Paper›PMID 40788763›Full record

ArticleNano letters2025

Selective Enhancement of the Optical Chirality and Spin Angular Momentum in Plasmonic Near-Fields.

Naoki Ichiji, Takuya Ishida, Ikki Morichika, Daigo Oue, Tetsu Tatsuma, Satoshi Ashihara

Abstract read
In one paragraph

Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naoki IchijiInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo 153-8505, Japan.ORCID 0000-0001-5910-2405
Takuya IshidaInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo 153-8505, Japan.
Ikki MorichikaInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo 153-8505, Japan.ORCID 0000-0002-5730-246X
Daigo OueMetaphotonics Research Team, RIKEN Centre for Advanced Photonics, Saitama 351-0198, Japan.ORCID 0000-0002-7113-9216
Tetsu TatsumaInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo 153-8505, Japan.ORCID 0000-0001-8738-9837
Satoshi AshiharaInstitute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo 153-8505, Japan.ORCID 0000-0001-6697-2513

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between circularly polarized (CP) light and matter is governed by two fundamental quantities: spin angular momentum (SAM) and optical chirality (OC). While these quantities are inseparable in free space, they can be selectively enhanced in plasmonic near-field regions through appropriately designed structures. We demonstrate that the excitation of circular plasmonic nanostructures with CP light enables the selective or simultaneous enhancement of the SAM and OC through the excitation of rotating plasmon modes. Electromagnetic field analysis reveals that SAM enhancement originates from transverse SAM induced by unidirectional evanescent waves, whereas OC enhancement is governed by the interference between the plasmonic electric field and the incident magnetic field. The finite-element method simulations confirm that circular differential absorption signals arising from these enhanced near-fields clearly depend on the SAM and OC of the local fields, underscoring the importance of structural design in the detection and enhancement of CP light-matter interactions at the nanoscale.

Indexed as

circular dichroismoptical chiralityplasmonic nanoantennaplasmonic nanoholespin angular momentum

Identifiers

PMID40788763
PMCPMC12372797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.